Santhera Pharmaceuticals raises CHF 20 million in growth funding led by R-Bridge and Highbridge Capital Management to accelerate global AGAMREE rollout.
Amount Raised
CHF20 Million
Round Type
Funding Round
PrattelnBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaPharmaceutical ManufacturingpharmaceuticalsInvestors
Description
Santhera Pharmaceuticals has secured CHF 20 million in funding to support the global rollout of AGAMREE. This financing includes USD 13 million from R-Bridge and an additional CHF 10 million from Highbridge. The funds will help increase inventory in China and accelerate launches globally. Demand for AGAMREE continues to exceed expectations across the US, Europe, and China.
Quick answer
Santhera Pharmaceuticals raised CHF20 Million in a Funding Round round, dated September 23, 2025. Investors: R Bridge and Highbridge Capital Management. Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland.
- How much did Santhera Pharmaceuticals raise?
- Santhera Pharmaceuticals raised CHF20 Million in a Funding Round round on September 23, 2025.
- Who invested in Santhera Pharmaceuticals?
- R Bridge and Highbridge Capital Management are named as investors in this round.
- What does Santhera Pharmaceuticals do?
- Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
- Where is Santhera Pharmaceuticals based and how big is it?
- Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland. Fundz records about 78 employees.
- Who are the decision-makers at Santhera Pharmaceuticals?
- Fundz holds 1 contact at Santhera Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Santhera Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- Minerva Neurosciences raised $200M (Funding Round) on October 21, 2025.
- Acasti raised $4M (Funding Round) on October 23, 2025.
- ISOThrive raised $8.1M on October 10, 2025.
- TORL BioTherapeutics raised $96M (Series C) on October 7, 2025.
- Os Therapies raised $3.8M on September 2, 2025.
- TNF Pharmaceuticals raised $7M on September 2, 2025.
Who to call at Santhera Pharmaceuticals, and when
A new round usually means Santhera Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Santhera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Santhera Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Santhera Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Santhera Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Santhera Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.